158 related articles for article (PubMed ID: 36367591)
1. Bacterial Metabolism-Initiated Nanocatalytic Tumor Immunotherapy.
Wu W; Pu Y; Gao S; Shen Y; Zhou M; Yao H; Shi J
Nanomicro Lett; 2022 Nov; 14(1):220. PubMed ID: 36367591
[TBL] [Abstract][Full Text] [Related]
2. Nanocatalysts-Augmented and Photothermal-Enhanced Tumor-Specific Sequential Nanocatalytic Therapy in Both NIR-I and NIR-II Biowindows.
Feng W; Han X; Wang R; Gao X; Hu P; Yue W; Chen Y; Shi J
Adv Mater; 2019 Feb; 31(5):e1805919. PubMed ID: 30536723
[TBL] [Abstract][Full Text] [Related]
3. Core-shell FePt-cube@covalent organic polymer nanocomposites: a multifunctional nanocatalytic agent for primary and metastatic tumor treatment.
Meng Y; Zhang D; Sun Y; Dai Z; Zhang T; Yu D; Zhang G; Zheng X
J Mater Chem B; 2020 Dec; 8(48):11021-11032. PubMed ID: 33191409
[TBL] [Abstract][Full Text] [Related]
4. Ultrasmall Cu
Hu R; Fang Y; Huo M; Yao H; Wang C; Chen Y; Wu R
Biomaterials; 2019 Jun; 206():101-114. PubMed ID: 30927714
[TBL] [Abstract][Full Text] [Related]
5. Near Infrared-Triggered Theranostic Nanoplatform with Controlled Release of HSP90 Inhibitor for Synergistic Mild Photothermal and Enhanced Nanocatalytic Therapy with Hypoxia Relief.
Tian B; Wang C; Du Y; Dong S; Feng L; Liu B; Liu S; Ding H; Gai S; He F; Yang P
Small; 2022 Jul; 18(28):e2200786. PubMed ID: 35661402
[TBL] [Abstract][Full Text] [Related]
6. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy.
Liang R; Li Y; Huo M; Lin H; Chen Y
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42917-42931. PubMed ID: 31635454
[TBL] [Abstract][Full Text] [Related]
7. Boosting Reactive Oxygen Species Generation with a Dual-Catalytic Nanomedicine for Enhanced Tumor Nanocatalytic Therapy.
Su G; Xu H; Zhou F; Gong X; Tan S; He Y
ACS Appl Mater Interfaces; 2023 Dec; 15(51):59175-59188. PubMed ID: 38095444
[TBL] [Abstract][Full Text] [Related]
8. Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy.
Noh I; Son Y; Jung W; Kim M; Kim D; Shin H; Kim YC; Jon S
Biomaterials; 2021 Aug; 275():120926. PubMed ID: 34147723
[TBL] [Abstract][Full Text] [Related]
9. Dual Size/Charge-Switchable Nanocatalytic Medicine for Deep Tumor Therapy.
Wu W; Pu Y; Shi J
Adv Sci (Weinh); 2021 May; 8(9):2002816. PubMed ID: 33977044
[TBL] [Abstract][Full Text] [Related]
10. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
[TBL] [Abstract][Full Text] [Related]
11. Photothermal-reinforced and glutathione-triggered in Situ cascaded nanocatalytic therapy.
An P; Fan F; Gu D; Gao Z; Hossain AMS; Sun B
J Control Release; 2020 May; 321():734-743. PubMed ID: 32145265
[TBL] [Abstract][Full Text] [Related]
12. Infection microenvironment-activated nanoparticles for NIR-II photoacoustic imaging-guided photothermal/chemodynamic synergistic anti-infective therapy.
Yang N; Guo H; Cao C; Wang X; Song X; Wang W; Yang D; Xi L; Mou X; Dong X
Biomaterials; 2021 Aug; 275():120918. PubMed ID: 34058607
[TBL] [Abstract][Full Text] [Related]
13. Multifunctional MnO
Wang Q; Qu B; Li J; Liu Y; Dong J; Peng X; Zhang R
ACS Appl Mater Interfaces; 2022 Feb; 14(4):4980-4994. PubMed ID: 35050589
[TBL] [Abstract][Full Text] [Related]
14. Tumor Microenvironment-Modulated Nanozymes for NIR-II-Triggered Hyperthermia-Enhanced Photo-Nanocatalytic Therapy via Disrupting ROS Homeostasis.
Zhu L; Dai Y; Gao L; Zhao Q
Int J Nanomedicine; 2021; 16():4559-4577. PubMed ID: 34267513
[TBL] [Abstract][Full Text] [Related]
15. Photothermal therapies to improve immune checkpoint blockade for cancer.
Balakrishnan PB; Sweeney EE; Ramanujam AS; Fernandes R
Int J Hyperthermia; 2020 Dec; 37(3):34-49. PubMed ID: 33426992
[TBL] [Abstract][Full Text] [Related]
16. Cu-Chelated polydopamine nanoparticles as a photothermal medium and "immunogenic cell death" inducer for combined tumor therapy.
Xu N; Hu A; Pu X; Wang J; Liao X; Huang Z; Yin G
J Mater Chem B; 2022 Apr; 10(16):3104-3118. PubMed ID: 35348176
[TBL] [Abstract][Full Text] [Related]
17. Acidic TME-Responsive Nano-Bi
Li Y; Yu H; Ren J; Lu G; Cao Y; Xu Z; Kang Y; Xue P
Small; 2022 Jan; 18(2):e2104302. PubMed ID: 34761867
[TBL] [Abstract][Full Text] [Related]
18. Nanocatalysts-augmented Fenton chemical reaction for nanocatalytic tumor therapy.
Qian X; Zhang J; Gu Z; Chen Y
Biomaterials; 2019 Aug; 211():1-13. PubMed ID: 31075521
[TBL] [Abstract][Full Text] [Related]
19. Multifunctional Magnetic Copper Ferrite Nanoparticles as Fenton-like Reaction and Near-Infrared Photothermal Agents for Synergetic Antibacterial Therapy.
Liu Y; Guo Z; Li F; Xiao Y; Zhang Y; Bu T; Jia P; Zhe T; Wang L
ACS Appl Mater Interfaces; 2019 Sep; 11(35):31649-31660. PubMed ID: 31407880
[TBL] [Abstract][Full Text] [Related]
20. NIR-II-driven and glutathione depletion-enhanced hypoxia-irrelevant free radical nanogenerator for combined cancer therapy.
Zhang L; Fan Y; Yang Z; Yang M; Wong CY
J Nanobiotechnology; 2021 Sep; 19(1):265. PubMed ID: 34488803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
